View Document Preview and Link Document Date: 2010-06-02 06:21:57 Open Document File Size: 1,23 MB Share Result on Facebook
City Moscow / Karolinska Institutet / / Company Adult SCs / EU Official Journal / High-Level Expert Group / SCs / / Continent Europe / / Country Netherlands / Bulgaria / Cyprus / Norway / France / Portugal / United Kingdom / Lithuania / Finland / Denmark / Germany / Romania / Croatia / Italy / Slovenia / Sweden / Poland / Belgium / Turkey / United States / Luxembourg / Spain / Ireland / Czech Republic / / Currency USD / / Event Product Issues / / Facility University of Kuopio / / IndustryTerm cell bank / pharmaceutical form / good culture systems / biotech applications / pharmaceutical regulatory resource / investigational medicinal products / Differentiation protocols / endogenous repair systems / unprecedented cell banking / culture media / medicinal products / potential applications / pharmaceuticals / bank / treatment of Parkinson’s disease / treatment of neurodegenerative disorders / treatment of various human diseases / treatment for his ataxia telangiectasia syndrome / private cord banking services / combination products / animal substancefree products / xeno-free culture systems / gene therapy medicinal product / clinical applications / biotechnology / gene delivery systems / therapies for many injuries / disorders / personal cord blood banking / hESC technology / personal cord blood bank / manufacturing practice / transplant systems / treatment of many diseases / possible solution / somatic cell therapy medicinal product / therapeutic tools / medicinal product / banking / sufficient infrastructure / attractive advertising / / MedicalCondition periodontitis / severe teratomas / amyotrophic lateral sclerosis / teratoma formation / multiple sclerosis / liver cirrhosis / human diseases / brain tumour / infertility / leukemia / cancer / severe diseases / ataxia telangiectasia syndrome / diabetes / Parkinson’s disease / diseases / spontaneous abortion / disorders / tumours / muscular dystrophy / public disorder / osteomalacia / vascular diseases / graft-versus-host disease / serious and disabling diseases / heart disease / severe chronic myocardial ischaemia / potential host-to-graft disease / infectious agents / neurodegenerative disorders / spinal cord injury / teratoma / congenital defects / disease / Crohn’s disease / tumour / osteoarthritis / myocardial infarction / chronic diseases / congenital birth defect / neurodegenerative diseases / injuries / / MedicalTreatment surgery / immunosuppression / innovative therapies / cell therapy / bone marrow transplants / bone marrow transplant / gene therapy / immunosuppressive therapy / / Organization Council of Ministers / Supreme Court / European Parliament / Enlarged Board / EMRC Standing Committee / European Commission / European Patent Office / European Science Foundation / European Union / German Federal Supreme Court / National Institute of Health / Food and Drug Administration / International Society for Stem Cell Research / Europe SC / Human Fertilisation and Embryology Authority / University of Kuopio / Council on the Legal Protection of Biotechnological Inventions / EPC / European Medicines Agency / European Court of Justice / EU Council / UK Intellectual Property Office / / Person Cells Directive / Katja Puttonen / Liselotte Højgaard / Austin Smith / Marja Makarow / / Position Chief Executive / Professor / Major / ESF Forward / Governor / Chair / / Product ESCs / heart tissue / versions / / ProgrammingLanguage EC / / ProvinceOrState South Carolina / / PublishedMedium the EU Official Journal / / Technology cell therapy / Differentiation protocols / stem cells / html / drug discovery / biomaterials / tissue engineering / nuclear transfer / biotechnology / cloning / Transplantation / hESC technology / pdf / gene therapy / gene delivery / http / drug development / Regenerative Medicine / SC technologies / / URL www.sc4sm.org / http / SocialTag 
SPB38_HumanStemCell_16p.May10.indd